Typicality: | 0.375 |
Saliency: | 0.293 |
in these trials | 3 | location |
to placebo | 2 | other |
cimetidine → be → superior | 4 |
negative | neutral | positive |
0.080 | 0.551 | 0.368 |
Raw frequency | 4 |
Normalized frequency | 0.293 |
Modifier score | 0.500 |
Perplexity | 386.781 |